Karen Zaderej

Track

Insider profile

Currently holds a position at AxoGen, Inc.

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 79% 68% 82%
Transactions
11 55% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer AxoGen, Inc. May 21, 2018 -
Independent Director Viveve Medical Inc Sept. 13, 2018 - May 4, 2020
President, Chief Executive Officer, Director AxoGen, Inc. Sept. 30, 2011 - May 21, 2018
Karen Zaderej's trades of EyePoint Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US EyePoint Inc (EYPT)
Transaction date
Purchase
Price
95.53
Quantity 87,274 +24.7%
Value US$133,085
US EyePoint Inc (EYPT)
Transaction date
Purchase
Price
63.77
Quantity 93,394 -36.4%
Value US$1,751,587
US EyePoint Inc (EYPT)
Transaction date
Purchase
Price
163.49
Quantity 63,270 -18.8%
Value US$3,560,782
US EyePoint Inc (EYPT)
Transaction date
Purchase
Price
5.47
Quantity 5,000 +23.3%
Value US$27,350
US EyePoint Inc (EYPT)
Transaction date
Purchase
Price
5.42
Quantity 5,000 +30.3%
Value US$27,100
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
18.41
Quantity 220,000
Value US$4,050,000
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
18.00
Quantity 100,000
Value US$1,800,000
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
12.71
Quantity 70,000
Value US$890,000
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
13.00
Quantity 150,000
Value US$1,950,000
US EyePoint Inc (EYPT)
Transaction date
Purchase
Price
7.98
Quantity 12,500 +312.5%
Value US$99,750
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
10.00
Quantity 200,000
Value US$2,000,000
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
7.68
Quantity 3,166 -0.3%
Value US$24,315
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
7.68
Quantity 3,086 -0.3%
Value US$23,700
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
7.68
Quantity 33,028 -2.9%
Value US$253,655
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
20.00
Quantity 65,000 -9.6%
Value US$1,300,000
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
17.81
Quantity 3,500 -0.5%
Value US$62,335
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
16.42
Quantity 1,275 -0.2%
Value US$20,936
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
14.53
Quantity 14,000 -2.1%
Value US$203,420
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-18
US EyePoint Inc (EYPT)
B Purchase
87,274 +24.7%
95.53
US$133,085 		87,274 +24.7% 95.53 US$133,085
2025-05-19 2025-05-19
US EyePoint Inc (EYPT)
B Purchase
93,394 -36.4%
63.77
US$1,751,587 		93,394 -36.4% 63.77 US$1,751,587
2025-05-19 2025-05-16
US EyePoint Inc (EYPT)
B Purchase
63,270 -18.8%
163.49
US$3,560,782 		63,270 -18.8% 163.49 US$3,560,782
2025-05-15 2025-05-15
US EyePoint Inc (EYPT)
B Purchase
5,000 +23.3%
5.47
US$27,350 		5,000 +23.3% 5.47 US$27,350
2025-05-15 2025-05-14
US EyePoint Inc (EYPT)
B Purchase
5,000 +30.3%
5.42
US$27,100 		5,000 +30.3% 5.42 US$27,100
2025-01-21 2025-01-21
US AxoGen, Inc. (AXGN)
PrS Proposed sale
220,000
18.41
US$4,050,000 		220,000 18.41 US$4,050,000
2025-01-14 2025-01-14
US AxoGen, Inc. (AXGN)
PrS Proposed sale
100,000
18.00
US$1,800,000 		100,000 18.00 US$1,800,000
2024-11-07 2024-11-07
US AxoGen, Inc. (AXGN)
PrS Proposed sale
70,000
12.71
US$890,000 		70,000 12.71 US$890,000
2024-09-05 2024-09-05
US AxoGen, Inc. (AXGN)
PrS Proposed sale
150,000
13.00
US$1,950,000 		150,000 13.00 US$1,950,000
2024-08-21 2024-08-19
US EyePoint Inc (EYPT)
B Purchase
12,500 +312.5%
7.98
US$99,750 		12,500 +312.5% 7.98 US$99,750
2024-08-12 2024-08-12
US AxoGen, Inc. (AXGN)
PrS Proposed sale
200,000
10.00
US$2,000,000 		200,000 10.00 US$2,000,000
2024-03-25 2024-03-21
US AxoGen, Inc. (AXGN)
S Sale
3,166 -0.3%
7.68
US$24,315 		3,166 -0.3% 7.68 US$24,315
2024-03-25 2024-03-21
US AxoGen, Inc. (AXGN)
S Sale
3,086 -0.3%
7.68
US$23,700 		3,086 -0.3% 7.68 US$23,700
2024-03-25 2024-03-21
US AxoGen, Inc. (AXGN)
S Sale
33,028 -2.9%
7.68
US$253,655 		33,028 -2.9% 7.68 US$253,655
2021-01-12 2021-01-08
US AxoGen, Inc. (AXGN)
PlS Planned sale
65,000 -9.6%
20.00
US$1,300,000 		65,000 -9.6% 20.00 US$1,300,000
2020-12-30 2020-12-29
US AxoGen, Inc. (AXGN)
S Sale
3,500 -0.5%
17.81
US$62,335 		3,500 -0.5% 17.81 US$62,335
2020-12-22 2020-12-21
US AxoGen, Inc. (AXGN)
S Sale
1,275 -0.2%
16.42
US$20,936 		1,275 -0.2% 16.42 US$20,936
2020-11-10 2020-11-09
US AxoGen, Inc. (AXGN)
PlS Planned sale
14,000 -2.1%
14.53
US$203,420 		14,000 -2.1% 14.53 US$203,420